Pubblicazioni

The role of patient-reported outcome measures in the continuum of cancer clinical care: ESMO Clinical Practice Guideline

2022 - ANNALS OF ONCOLOGY

Di Maio, M.; Basch, E.; Denis, F.; Fallowfield, L. J.; Ganz, P. A.; Howell, D.; Kowalski, C.; Perrone, F.; Stover, A. M.; Sundaresan, P.; Warrington, L.; Zhang, L.; Apostolidis, K.; Freeman-Daily, J.; Ripamonti, C. I.; Santini, D.

Nutritional support reduces mortality in hospitalized patients with different types of cancers: secondary analysis of a prospective randomized trial.

2021 - ANNALS OF ONCOLOGY

Bargetzi, L.; Brack, C.; Herrmann, J.; Bargetzi, A.; Hersberger, L.; Bargetzi, M.; Kaegi-Braun, N.; Tribolet, P.; Gomes, F.; Hoess, C.; Pavlicek, V.; Bilz, S.; Sigrist, S.; BrÃ¤ndle, M.; Henzen, C.; Thomann, R.; Rutishauser, J.; Aujesky, D.; Rodondi, N.; DonzÃ©, J.; Laviano, A.; Stanga, Z.; Mueller, B.; Schuetz, P.

Neoantigen prediction and computational perspectives towards clinical benefit: recommendations from the ESMO Precision Medicine Working Group

2020 - ANNALS OF ONCOLOGY

De Mattos-Arruda, L; Vazquez, M; Finotello, F; Lepore, R; Porta, E; Hundal, J; Amengual-Rigo, P; Ng, C K Y; Valencia, A; Carrillo, J; Chan, T A; Guallar, V; Mcgranahan, N; Blanco, J; Griffith, M

A randomized, double-blind, placebo-controlled, multicenter study of a ginger extract in the management of chemotherapy-induced nausea and vomiting (CINV) in patients receiving high dose cisplatin

2017 - ANNALS OF ONCOLOGY

Bossi, P; Cortinovis, D; Fatigoni, S; Cossu Rocca, M; Fabi, A; Seminara, Patrizia; Ripamonti, C; Alfieri, S; Granata, R; Bergamini, C; Agustoni, F; Bidoli, P; NolÃ¨, F; Pessi, M. A; Macchi, F; Michellini, L; Montanaro, F; Roila, F.

Clinical validity of tumor-infiltrating lymphocytes analysis in patients with triple-negative breast cancer

2016 - ANNALS OF ONCOLOGY

Pruneri, G; Vingiani, A; Bagnardi, V; Rotmensz, N; De Rose, A; Palazzo, Antonella; Colleoni, A. M; Goldhirsch, A; Viale, G.

Long non-coding RNA HSAT II as a new biomarker for the identification of high risk intraductal papillary mucinous neoplasms (IPMNs)

2015 - ANNALS OF ONCOLOGY

Pantano, F; Perrone, G; Vincenzi, B; Iuliani, M; Fioramonti, M; Zoccoli, A; Ribelli, G; Borzomati, D; Nappo, G; Pellegrini, C; Amato, Mm; Righi, D; Di Matteo, Fm; Trodella, L; Santini, D; Coppola, R; Onetti Muda, A; Tonini, G